Your search history is turned on.
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Isracann - News Release announcing resignation of directors and officers (e(43754466.1).docx LEGAL_43754466.1 Isracann Biosciences Announces Management Changes VANCOUVER, BC, (January 22, 2024) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that Sean Bromley, Yana Popova, Desmond Balakrishnan and G...
Date: March 3, 2023 Jurisdictions: Alberta, British Columbia, Ontario
LEGAL_40823805.1 Isracann Biosciences Provides Bi-Weekly Default Status Report VANCOUVER, BC, -- (March 1, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that further to its news release dated February 1, 2023 (the Default Announcement), the Companys principal regulator, the British Columbia Securities Commis...
Date: February 17, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - IPOT - Feb 16 - Press Release re Closing of PP.docx Isracann Biosciences Announces Closing of $0.05 Unit Private Placement VANCOUVER, BC, -- (February 16, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) is pleased to announce that it has closed a non-brokered private placement, whereby the Company issue...
Date: February 15, 2023 Jurisdictions: Alberta, British Columbia, Ontario
LEGAL_40655283.1.docx Isracann Biosciences Provides Bi-Weekly Default Status Report VANCOUVER, BC, -- (February 15, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that further to its news release dated February 1, 2023 (the Default Announcement), the Companys principal regulator, the British Columbia Securiti...
Date: February 1, 2023 Jurisdictions: Alberta, British Columbia, Ontario
LEGAL_40510804.1 Isracann Biosciences Announces Delay in Filing Second Quarter Interim Financial Statements VANCOUVER, BC, -- (February 1, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that the filing of its unaudited interim financial statements for the second quarter ended November 30, 2022, including the re...
Date: January 27, 2023 Jurisdictions: All jurisdictions
January 27, 2023 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: ISRACANN BIOSCIENCES INC. Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual Gene...
Date: January 24, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Form 51102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Isracann Biosciences Inc. (the Company) 1600 595 Burrard Street Vancouver, BC V7X 1L3 Item 2. Date of Material Change January 20, 2023 Item 3. News Release A news release dated January 20, 2023 was disseminated via Stockwatch and subsequently...
Date: January 23, 2023 Jurisdictions: Alberta, British Columbia, Ontario
LEGAL_40523209.1 Isracann Biosciences Announces Interim CEO VANCOUVER, BC, (January 20, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces the appointment of Ajay Singh Kaila as interim CEO, effective January 20, 2023. ON BEHALF OF THE BOARD OF DIRECTORS Sean Bromley Sean Bromley Director A...
Date: January 17, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Isracann - Material Change Report re Resignation of Directors and Officers (Jan 2023).DOCX Form 51102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Isracann Biosciences Inc. (the Company) 1600 595 Burrard Street Vancouver, BC V7X 1L3 Item 2. Date of Material Change December 15, 2022, January 11, 2023 and January 15...
Microsoft Word - Isracann - News Release announcing Resignation of COO (Jan 2023).DOCX LEGAL_40523209.1 Isracann Biosciences Announces Resignation of COO VANCOUVER, BC, (January 17, 2023) Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that James (JT) Thompson resigned as Chief Operations Officer of the Company, ...